Abstract
Tryptamine levels have been determined in mouse brain regions and spinal cord and in rat spinal cord. They were; caudate nucleus 2.5 ng·g−1, hypothalamus <0.5 ng·g−1, hippocampus <0.7 ng·g−1, olfactory bulb <0.7 ng·g−1, olfactory tubercles <0.6 ng·g−1, brain stem <0.4 ng·g−1, cerebellum <1.0 ng·g−1, and the “rest” 0.9 ng·g−1. The mouse whole brain was found to have 0.5 ng·g−1, the mouse spinal cord 0.3 ng·g−1, and the rat spinal cord 0.3 ng·g−1. These concentrations increased rapidly to 22.8 ng·g−1, 14.2 ng·g−1, and 6.6 ng·g−1 respectively at 1 hr after 200 mg·kg−1 pargyline. The turnover rates and half lives of tryptamine in the mouse brain and spinal cord and rat spinal cord were estimated to be 0.14 nmol·g−1·h−1 and 0.9 min; 0.054 nmol·g−1·h−1 and 1.5 min and 0.04 nmol·g−1·h−1 and 1.6 min respectively. The aromaticl-aminoacid decarboxylase inhibitors NSD 1034 and NSD 1055 reduced synthesis of tryptamine in controls and pargyline pretreated animals. Tryptophan increased the concentrations of mouse striatal tryptamine and 5-hydroxytryptamine and brain stem 5-hydroxyindole acetic acid.p-Chlorophenylalanine reduced formation of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid but did not change that of tryptamine.
Similar content being viewed by others
References
Hess, S. M., andUdenfriend, S. 1959. A fluorimetric procedure for the measurement of tryptamine in tissues. J. Pharmac. Exp. Ther. 127:175–177.
Eccleston, D., Ashcroft, G. W., Crawford, T. B. B., andLoose, R. 1966. Some observations on the estimation of tryptamine in tissues. J. Neurochem. 13:93–101.
Martin, W. R., Sloan, J. W., Christian, S. T., andClements T. H. 1972. Brain levels of tryptamine. Psychopharmacol. 23:331–346.
Saavedra, J. M., andAxelrod, J. 1972. A specific and sensitive enzymatic assay for tryptamine in tissues. J. Pharmacol. Exp. Ther. 182:363–369.
Snodgrass, S. R., andHorn, A. S. 1973. An assay procedure for tryptamine in brain and spinal cord using its [3H]dansyl derivative. J. Neurochem. 21:687–696.
Marsden, C. A., andCurzon, G. 1974. Effects of lesions and drugs on brain tryptamine. J. Neurochem. 23:1171–1176.
Philips, S. R., Durden, D. A., andBoulton, A. A. 1974. Identification and distribution of tryptamine in the rat. Can. J. Biochem. 52:447–451.
Warsh, J. J., Godse, D. D., Stancer, H. C., Chan, P. W., andCoscina, D. V. 1977. Brain tryptamine in rats by a new gas chromatography-mass fragmentographic method. Biochem. Med. 18:10–20.
Sloan, J. W., Martin, W. R., Clements, T. H., Buchwald, W. F., andBridges, S. R. 1975. Factors influencing brain and tissue levels of tryptamine: species, drugs and lesions. J. Neurochem. 24:523–532.
Neff, N. H., andYang, H.-Y.T. 1974. Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs. Life Sci. 14:2061–2074.
Meek, J. L., Krall, A. R., andLipton, M. A. 1970. Psychotropic drugs and the metabolism of intracerebrally injected tryptamine, 5-hydroxytryptamine and norepinephrine. J. Neurochem. 17:1627–1635.
Wu, P. H., andBoulton, A. A. 1973. Distribution and metabolism of tryptamine in rat brain. Can. J. Biochem. 51:1104–1112.
Durden, D. A., andPhilips, S. R. 1980. Kinetic measurement of the turnover rates of phenylethylamine and tryptamine in vivo in the rat brain. J. Neurochem. 34:1725–1732.
Juorio, A. V., andKazakoff, C. W. 1984. The presence of β-phenylethylamine,p-tyramine,m-tyramine and tryptamine in ganglia and foot muscle of the garden snail (Helix aspersa). Experientia 40:549–551.
Bogdanski, D. E., Pletscher, A. Brodie, B. B., andUdenfriend, S. 1956. Identification and assay of serotonin in brain. J. Pharmacol. Exp. Ther. 117:82–88.
Giacalone, E., andValzelli, L. 1966. A method for the determination of 5-hydroxyindolyl-3-acetic acid in brain. J. Neurochem. 13:1265–1266.
Warsh, J. J., Coscina, D. V., Godse, D. D., andChan, P. W. 1979. Dependence of brain tryptamine formation on tryptophan availability. J. Neurochem. 32:1191–1196.
Juorio, A. V. 1982. The effects of some antipsychotic drugs, D-amphetamine, and reserpine on the concentration and rate of accumulation of tryptamine and 5-hydroxytryptamine in the mouse striatum. Can. J. Physiol. Pharmacol. 60:376–380.
Jones, R. S. G., andBoulton, A. A. 1980. Tryptamine and 5-hydroxytryptamine actions and interactions on cortical neurones in the rat. Life Sci. 27:1849–1856.
Saavedra, J. M., andAxelrod, J. 1973. Effect of drugs on the tryptamine content of rat tissues. J. Pharmacol. Exp. Ther. 185:523–529.
Koe, B. K., andWeissman, A. 1966.p-Chlorophenylalanine: a specific depletor of brain serotonin. J. Pharmac. Exp. Ther. 154:499–516.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Juorio, A.V., Durden, D.A. The distribution and turnover of tryptamine in the brain and spinal cord. Neurochem Res 9, 1283–1293 (1984). https://doi.org/10.1007/BF00973040
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00973040